CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes

Moritz Rapp(Center for Integrated Protein Science Munich), Maximilian W. M. Wintergerst(Center for Integrated Protein Science Munich), Wolfgang G. Kunz(Center for Integrated Protein Science Munich), Viola Katharina Vetter(Center for Integrated Protein Science Munich), Maximilian M. L. Knott(Center for Integrated Protein Science Munich), Dominik Lisowski(Center for Integrated Protein Science Munich), Sascha Haubner(Center for Integrated Protein Science Munich), Stefan Moder(Center for Integrated Protein Science Munich), Raffael Thaler(Center for Integrated Protein Science Munich), Stephan Eiber(Center for Integrated Protein Science Munich), Bastian Meyer(Center for Integrated Protein Science Munich), Natascha Röhrle(Center for Integrated Protein Science Munich), Ignazio Piseddu(Center for Integrated Protein Science Munich), Simon Grassmann(Institute of Medical Microbiology and Hygiene), Patrick Layritz(Center for Integrated Protein Science Munich), Benjamin Kühnemuth(Center for Integrated Protein Science Munich), Susanne Stutte(Harvard University), Carole Bourquin(University of Geneva), Ulrich H. von Andrian(Harvard University), Stefan Endres(Center for Integrated Protein Science Munich), David Anz(Center for Integrated Protein Science Munich)
The Journal of Experimental Medicine
March 25, 2019
Cited by 268Open Access
Full Text

Abstract

Chemokines have crucial roles in organ development and orchestration of leukocyte migration. The chemokine CCL22 is expressed constitutively at high levels in the lymph node, but the functional significance of this expression is so far unknown. Studying a newly established CCL22-deficient mouse, we demonstrate that CCL22 expression by dendritic cells (DCs) promotes the formation of cell-cell contacts and interaction with regulatory T cells (T reg) through their CCR4 receptor. Vaccination of CCL22-deficient mice led to excessive T cell responses that were also observed when wild-type mice were vaccinated using CCL22-deficient DCs. Tumor-bearing mice with CCL22 deficiency showed prolonged survival upon vaccination, and further, CCL22-deficient mice had increased susceptibility to inflammatory disease. In conclusion, we identify the CCL22-CCR4 axis as an immune checkpoint that is crucial for the control of T cell immunity.


Related Papers

No related papers found

Powered by citation graph analysis